GLP-1 Compounding After Shortages: Impurity Data Reshapes Peptide Debate
A 2026 impurity finding in compounded tirzepatide-vitamin B12 samples and a 22-vial recall sharpen the debate over GLP-1 compounding after FDA resolved the shortages.
Read article →